Urology

Journal of the American College of Surgeons

Volumn 188, Issue 2, 1999, Pages 198-201

  Richie, Jerome P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER ASSISTED TOMOGRAPHY; CYSTOURETHROGRAPHY; IMPOTENCE; MALE INFERTILITY; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; REVIEW; UROLOGY; VESICOURETERAL REFLUX;

EID: 0033024771     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(98)00279-8     Document Type: Article

References (27)

1. Catalona WJ, Partin AW, Slawin KM, et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multi-center clinical trial. JAMA 1998;279:1542-1547.
2. Smith JR, Freije D, Carpten JC, et al. Major susceptibility locus for prostate cancer on chromosome one suggested by a genome wide search. Science 1997;91:1371-1374.
3. D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998;280:969-974.
4. Albertsen PC, Hanley JA, Gleason DF, Barry MJ. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 1998;280:975-980.
5. Savage SJ, Ost MC, Droller MJ, Liu BC. Receptor and postreceptor mechanisms of transforming growth factor-B resistance in human prostate cancer cells. Surg Forum 1998;XLIX:677-679.
6. Gattas N, Richie JP, Lu ML. Overexpression of a new candidate tumor suppressor PTEN gene causes decreased cell growth rate and tumorigenicity in human prostate carcinoma cells. Surg Forum 1998;XLIX:671-672.
7. Paterson DL, Patel A. Bacillus Calmette-Guérin (BCG) immunotherapy for bladder cancer: review of complications and their treatment. Aust N Z J Surg 1998;68:340-344.
8. Waingold AL, Leung RL, Loughlin KR, Gaston SM. Preclinical analysis of lectin-triggered apoptosis as an alternative intravesical chemotherapeutic strategy for transitional cell carcinoma of the bladder. Surg Forum 1998;XLIX:673-675.
9. Stein JP, Grossfeld GD, Ginsberg DA, et al. Prognostic markers in bladder cancer: a contemporary review of the literature. J Urol 1998;160:645-659.
10. Blute ML, Gburek BM. Continent orthotopic urinary diversion in female patients: early Mayo Clinic experience. Mayo Clinic Proc 1998;73:501-507.
11. McConnell JD, Bruskewitz R, Walsh P, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. N Engl J Med 1998;338:557-563.
12. Michel MC, Mehlburger L, Bressel HU, et al. Tamsulosin treatment of 19,365 patients with lower urinary tract symptoms: does co-morbidity alter tolerabiliry? J Urol 1998;160:784-791.
13. Beduschi MC, Oesterling JE. Transurethral needle ablation of the prostate: a minimally invasive treatment for symptomatic benign prostatic hyperplasia. Mayo Clinic Proc 1998;73:696-701.
14. Eliasson T, Damber JE. Temperature controlled high energy transurethral microwave thermotherapy for benign prostatic hyperplasia using a heat shock strategy. J Urol 1998;160:777-781.
15. Hallin A, Berlin T. Transurethral microwave thermotherapy for benign prostatic hyperplasia: clinical outcome after 4 years. J Urol 1998;159:459-464.
16. Bruskewitz R, Issa MM, Roehrborn CG, et al. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia. J Urol 1998;159: 1588-1593.
17. Goldstein I, Lue TF, Padma-Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998;338: 1397-1404.
18. Sam AD, Sharma AC, Law WR, et al. The role of nitric oxide in regulating testicular blood flow and testosterone production during sepsis. Surg Forum 1998;XLIX:667-669.
19. Klotz T, Bloch W, Volberg C, et al. Selective expression of inducible nitric acid oxide synthase in human prostate carcinoma. Cancer 1998;82:1897-1903.
20. Oei SG, Helmerhorst FM, Bloemenkamp KW, et al. Effectiveness of the postcoital test: randomised controlled trial. BMJ 1998;317:502-505.
21. Hutchon S, Thornton S, Hall J, Bishop M. Frozen-thawed epididymal sperm is effective for intracytoplasmic sperm injection: implications for the urologist. Br J Urol 1998;81:607-611.
22. Barak Y, Kogosowski A, Goldman S, et al. Pregnancy and birth after transfer of embryos that developed from single-nucleated zygotes obtained by injection of round spermatids into oocytes. Fertil Steril 1998;70:67-70.
23. Nguyen LB, Lievano G, Ghosh L, et al. Effects of unilateral testicular torsion on blood flow and histology of contralateral testis. Surg Forum 1998;XLIX:666-667.
24. Merkle EM, Wunderlich A, Aschoff AJ, et al. Virtual cystoscopy based on helical CT scan datasets: perspectives and limitations. Br J Radiol 1998;71:262-267.
25. Ferrer FA, McKenna PH, Hochman HI, Herndon A. Results of a vesicoureteral reflux practice pattern survey among American Academy of Pediatrics, Section on Pediatric Urology members. J Urol 1998;160:1031-1037.
26. Skobejko-Wlodarska L, Strulak K, Nachulewicz P, Szymkiewicz C. Bladder autoaugmentation in myelodysplastic children. Br J Urol 1998;81:114-116.
27. Ahmed S, Sen S. The Mitrofanoff procedure in paediatric urinary tract reconstruction. Aust NZJ Surg 1998;68:199-202.